Hancock Whitney Corp Voyager Therapeutics, Inc. Transaction History

Hancock Whitney Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$4.61 - $9.04 $259,082 - $508,047	-56,200 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$7.15 - $12.28 $28,056 - $48,186	-3,924 Reduced 6.53%	56,200 $402,000
Q3 2020 Nov 05, 2020	SELL	$10.01 - $13.75 $15,015 - $20,625	-1,500 Reduced 2.43%	60,124 $642,000
Q2 2020 Jul 30, 2020	SELL	$8.05 - $14.21 $107,298 - $189,405	-13,329 Reduced 17.78%	61,624 $778,000
Q1 2020 May 08, 2020	BUY	$6.8 - $14.66 $509,680 - $1.1 Million	74,953 New	74,953 $686,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $219M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.